新型范可尼贫血样IBMFS中ADH5/ALDH2缺陷疾病模型iPSCs分析
研究构建了ADH5/ALDH2缺陷的疾病模型细胞系(包括iPSCs),发现ADH5是甲醛防御主要酶,ALDH2为备份;患者来源iPSCs体外造血分化时扩增严重缺陷且DNA损伤增加,ALDH2激动剂C1可部分逆转该缺陷。
要点
- ADH5是抵御内源性甲醛的主要酶,ALDH2提供备份防御。
- ADH5/ALDH2缺陷iPSCs体外造血分化时扩增严重缺陷且DNA损伤增加。
- ALDH2激动剂C1可部分逆转疾病模型iPSCs的扩增缺陷。
核心结论
- ADH5/ALDH2缺陷导致内源性甲醛清除障碍,损害造血分化并增加DNA损伤,C1可能成为潜在治疗策略。
研究设计与样本
- 构建ADH5/ALDH2缺陷疾病模型细胞系(包括患者来源iPSCs),比较患者淋巴细胞与成纤维细胞的SCEs,并进行体外造血分化实验。
主要发现
- 患者PHA刺激的淋巴细胞自发性姐妹染色单体交换(SCEs)数量高度增加,而成纤维细胞SCEs水平正常。
- ADH5/ALDH2缺陷细胞系DNA修复能力可被外源性低剂量甲醛压倒,DNA损伤水平高于FANCD2缺陷细胞。
- ADH5/ALDH2缺陷细胞系健康且生长稳定,但疾病模型iPSCs体外造血分化时扩增严重缺陷并伴DNA损伤增加。
临床怎么用
- 对于ADH5/ALDH2双基因缺陷相关IBMFS,ALDH2激动剂C1可能作为潜在治疗策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
We have recently discovered Japanese children with a novel Fanconi anemia-like inherited bone marrow failure syndrome (IBMFS). This disorder is likely caused by the loss of a catabolic system directed toward endogenous formaldehyde due to biallelic variants in ADH5 combined with a heterozygous ALDH2*2 dominant-negative allele (rs671), which is associated with alcohol-induced Asian flushing. Phytohemagglutinin-stimulated lymphocytes from these patients displayed highly increased numbers of spontaneous sister chromatid exchanges (SCEs), reflecting homologous recombination repair of formaldehyde damage. Here, we report that, in contrast, patient-derived fibroblasts showed normal levels of SCEs, suggesting that different cell types or conditions generate various amounts of formaldehyde. To obtain insights about endogenous formaldehyde production and how defects in ADH5/ALDH2 affect human hematopoiesis, we constructed disease model cell lines, including induced pluripotent stem cells (iPSCs). We found that ADH5 is the primary defense against formaldehyde, and ALDH2 provides a backup. DNA repair capacity in the ADH5/ALDH2-deficient cell lines can be overwhelmed by exogenous low-dose formaldehyde, as indicated by higher levels of DNA damage than in FANCD2-deficient cells. Although ADH5/ALDH2-deficient cell lines were healthy and showed stable growth, disease model iPSCs displayed drastically defective cell expansion when stimulated into hematopoietic differentiation in vitro, displaying increased levels of DNA damage. The expansion defect was partially reversed by treatment with a new small molecule termed C1, which is an agonist of ALDH2, thus identifying a potential therapeutic strategy for the patients. We propose that hematopoiesis or lymphocyte blastogenesis may entail formaldehyde generation that necessitates elimination by ADH5/ALDH2 enzymes.
引用
- Mu A, Hira A, Niwa A, et al. Analysis of disease model iPSCs derived from patients with a novel Fanconi anemia-like IBMFS ADH5/ALDH2 deficiency. Blood. 2021. PMID: 33512438. doi:10.1182/blood.2020009111
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。